Published Date: 08 Mar 2023
Everything will be done better if it depends on engineering. Quality management and the best results will complement scientific research, within reach and make our environment.
Read Full NewsAbout one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.
A ‘target trial’ emulation study suggests that regular exercise can help breast cancer survivors live longer.
Broader implementation would require substantial investment, but long-term dividends of liquid biopsy analysis in the region could affect diagnosis and care of much more than just this cancer.
Counterintuitive findings hint that diets rich in fruit, vegetables, and whole grains may increase the risk of lung cancer in young nonsmokers, but experts are skeptical.
Photopenia in high CT density renal lesions on [18F]FDG PET/CT scans shows a high negative predictive value for excluding malignancy.
A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with azacitidine plus venetoclax for newly diagnosed acute myeloid leukemia.
Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease.
1.
Study identifies new approach to protect the brain during radiation therapy
2.
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL
3.
GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.
4.
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant
5.
November 2023, Medical Bulletin 04/.
1.
Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Everything You Need to Know About Normal Potassium Levels
4.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
5.
Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part V
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
3.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation